IQVIA Launches E360 Genomics
March 05 2019 - 7:00AM
Business Wire
First-of-its-kind patented privacy-preserving
technology platform
IQVIA™ (NYSE: IQV) today announced the launch of a patented
technology platform that advances real-world research and protects
genomic data privacy. E360™ Genomics, a scalable,
privacy-preserving genotypic-phenotypic database solution, provides
an efficient way to conduct genomic research with genomic and
clinical databases.
“Genomic data are critical to transforming clinical research and
healthcare delivery,” said Jon Resnick, president, Real-World &
Analytics Solutions at IQVIA. “This game-changing technology will
be a significant catalyst for scientific discovery, and improved
patient outcomes. It offers researchers more efficient and cost
effective access to genomic data while addressing privacy
concerns.”
E360 Genomics platform enables life science customers immediate
access to aggregated data at scale to conduct a wide range of
research including association studies of genomics and observable
traits, comparative efficacy and safety trials, and
burden-of-illness and discovery analytics using non-identified data
in a secure environment that protects patients’ privacy. IQVIA’s
patented techniques allow for the removal of phenotypic,
identifying information from genomic data while retaining the
critical linkage of clinical and genomics data to improve research
and healthcare delivery. The result is a more flexible and less
expensive approach for scientific inquiry into human biology, drug
discovery, and drug development.
Powered by IQVIA CORE™, the E360 Genomics platform can manage
the scale and complexity of genomic datasets and draw insights from
a significantly increased number of covariates while preserving
privacy. IQVIA CORE brings together a dynamic integration of
unparalleled data, transformative technology, advanced analytics
and essential domain expertise. IQVIA is committed to advancing
global public health by integrating data science and technology
with human science expertise to drive new discoveries and insights
from increasingly large and complex datasets.
Additional information about the E360 Genomics platform is
available at E360™ Genomics.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced
analytics, technology solutions and contract research services to
the life sciences industry. Formed through the merger of IMS Health
and Quintiles, IQVIA applies human data science — leveraging the
analytic rigor and clarity of data science to the ever-expanding
scope of human science — to enable companies to reimagine and
develop new approaches to clinical development and
commercialization, speed innovation and accelerate improvements in
healthcare outcomes. Powered by the IQVIA CORE, IQVIA delivers
unique and actionable insights at the intersection of large-scale
analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With more than 58,000
employees, IQVIA conducts operations in more than 100
countries.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors and
scientific advances, in an effort to advance their path toward
cures. To learn more, visit www.iqvia.com.
IQVIAFIN
Click here to subscribe to Mobile Alerts for IQVIA.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190305005262/en/
Tor Constantino, IQVIA Media Relations
(tor.constantino@iqvia.com)+1.484.567.6732Andrew Markwick, IQVIA
Investor Relations (andrew.markwick@iqvia.com)+1.973.257.7144
IQVIA (NYSE:IQV)
Historical Stock Chart
From Jun 2024 to Jul 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From Jul 2023 to Jul 2024